Reducing Our Impact on the Environment We are committed to conducting our operations in a way that minimises negative impact on the environment, protects biodiversity and conserves natural resources. Here are some of the ways we’re working to reduce our greenhouse gas (GHG) emissions: • Our European manufacturing sites have been using 100% renewable purchased electricity since early 2023. • In FY2025, our Scope 1 emissions remained stable, reflecting consistent operational performance. • We continue to implement our energy efficiency and emissions reduction roadmap to support our FY2030 targets. • Our Scope 2 emissions decreased by approximately 29% compared to FY2024, primarily due to our Australian sites transitioning to renewable electricity from 1 January 2025 under a Renewable‑Linked Power Purchase Agreement. Inclusion and Belonging Our 29,000+ people are at the heart of delivering our therapies that save lives, protect public health and support the patients and communities we serve – creating enduring impact for those who rely on us. Creating a culture where everyone belongs, develops and thrives is foundational to who we are as a company and is reflected in our Values. Our workforce reflects the patients and communities we serve. Our commitment to inclusion and belonging extends beyond our front doors. It is reflected in how we engage with and support the community where we live and work. One way we contribute is by providing employment opportunities for underrepresented members of the community. For over 10 years we have partnered with Valida, a Swiss social enterprise dedicated to providing individuals who have support needs with the opportunity for equal and self-determined access to work. Valida’s team assists with the manual packaging of small‑scale quantities of our iron and nephrology therapeutics at our Swiss manufacturing site. In Australia, we joined the Australian Disability Network in 2024, along with three other major employers in Australia, to launch the Employing 100 Program. This partnership with the Australian government seeks to successfully place 100 job seekers with disability into roles across the four companies. We’ve made solid progress in building a workforce that brings a broad range of perspectives to our work. We know there’s more to do to create an inclusive culture and make a positive impact in our communities. We’re committed to that work – and proud of the contribution our employees make every day. “ It’s vital that our employees mirror the patients, donors, and people we serve – so that we bring a wide variety of viewpoints to the important decisions we make and problems we solve.” Paul McKenzie, CEO and Managing Director, CSL 25 Limited Our Impact 2025 About CSL From our CEO Lifesaving Medicines Healthier Communities Science and Medicine Legacy
RkJQdWJsaXNoZXIy MjE2NDg3